Anonymous ID: 1fefca June 1, 2021, 12:04 p.m. No.58853   🗄️.is đź”—kun   >>8891 >>8918

US Supreme Court rejects J&J talc cancer case appeal

 

The US Supreme Court has declined to hear Johnson & Johnson's appeal over a pay-out to women who alleged that its talcum powder contained asbestos and caused them to develop ovarian cancer. The healthcare giant must pay $2.1bn (ÂŁ1.5bn) in damages to the women.

 

The top US court did not comment on its decision, but has left in place a 2018 verdict that favoured them. Johnson & Johnson (J&J) said decades of independent research show the product is safe. The company asked the court to review the penalty it had been given after it was upheld in Missouri in 2020.

 

The Missouri Court of Appeals ruled against J&J's request to throw out the compensation and punitive damages awarded to the women, but reduced the total pay-out from the $4.7bn originally decided by a jury. J&J argued that it should not have to defend itself in a case involving 20 women from different states, backgrounds, and who used its products to different degrees. The healthcare giant said: "The decision by the court to not review the Ingham case leaves unresolved significant legal questions that state and federal courts will continue to face on issues related to due process rights and personal jurisdiction. "The Supreme Court has many times said that its decision to deny hearing a case expresses no view on the merits whatsoever, and we continue to believe that our view of the law and the facts will ultimately prevail," it added.

 

It also pointed out that the matters in front of the court were related to legal procedure, not safety. "Decades of independent scientific evaluations confirm Johnson's Baby Powder is safe, does not contain asbestos, and does not cause cancer," it said. It has been at the centre of claims for many years that its talcum powder contains carcinogens. The brand has always strenuously defended the product's safety. However, it removed its talc-based baby powder from sale last year in the US and Canada, saying that sales had shrunk partly because of a "constant barrage" of advertising by lawyers seeking clients to claim against the company. Talc is mined from the earth and is found in seams close to that of asbestos, a material known to cause cancer. About 20,000 people in the US have so far lodged claims against the company, it said at the time.

 

The firm's baby powder it still sold in the UK and in other markets around the world, where it says there is still significant demand.

https://www.bbc.com/news/business-57322979

Anonymous ID: 1fefca June 1, 2021, 12:17 p.m. No.58854   🗄️.is đź”—kun   >>8891 >>8918

>>58716 pb World’s Largest Meat Supplier Crippled by Cyberattack

>>58718 From “Event 201” to “Cyber Polygon”: The WEF’s Simulation of a Coming “Cyber Pandemic”

 

muh russia

JBS cyberattack hits cattle futures, sparks food fears

 

Russia's bad actors are hitting US food and energy production with ease. After the world’s largest meat producer JBS Foods confirmed it was the victim of a ransomware attack, cattle futures took a hit.

 

In trading on the CME, futures fell over 3%, before curbing some of those losses, as traders attempt to handicap the potential disruption to both the U.S. and global food supply while reports circulate JBS may be shutting down plants in the U.S. and Australia. On Monday, the company stated, "JBS USA determined that it was the target of an organized cybersecurity attack, affecting some of the servers supporting its North American and Australian IT systems... resolution of the incident will take time, which may delay certain transactions with customers and suppliers."

 

On Tuesday, there were reports production facilities in both the U.S. and Australia were taken offline. Inquires by FOX Business to JBS were not returned at the time of publication. The White House is also working in tandem with the FBI and the U.S. Department of Agriculture to monitor the situation. "USDA has reached out to several major meat processors in the United States to ensure they are aware of the situation. We're assessing any impacts on supply and the president has directed to the administration to determine what we can do to mitigate any impacts as they may become necessary" said Karine Jean-Pierre, principal deputy press secretary.

 

She also said Russia is likely behind the attack. "In the last day, JBS notified the administration that the ransom demand came from a criminal organization likely based in Russia. The White House is engaging directly with the Russian government on this matter and delivering the message that responsible states do not harbor ransomware criminals," she stated. If the JBS hack isn’t solved soon it could cause very tight supplies for beef and pork and much higher costs for restaurants. It could also cause shortages of beef and pork like we saw at the beginning of the COVID-19 pandemic. Worst case scenario; restaurants could start to limit supply and we could see shortages if the producer is down for an extended period.

moar

https://www.foxbusiness.com/markets/jbs-cyber-attack-hits-cattle-futures-sparks-meat-fears

https://www.cmegroup.com/trading/agricultural/livestock/live-cattle.html#

Anonymous ID: 1fefca June 1, 2021, 12:28 p.m. No.58857   🗄️.is đź”—kun   >>8891 >>8918

WHO approves second Chinese COVID-19 vaccine for emergency use

 

The World Health Organization on Tuesday approved the second Chinese COVID-19 vaccine for emergency use, providing a possible boost to its global access initiative as concerns about trial data linger. Sinovac Biotech's CoronaVac joined Sinopharm and five other Western vaccines recognized by the WHO, which is trying to meet the global demand for inoculation.

 

An independent panel of experts at the WHO said in a statement it recommended Sinovac's vaccine for adults over 18, with a second dose two to four weeks later. There was no upper age limit as data suggested it is likely to have a protective effect in older people. Over 270 million doses of CoronaVac have been administered so far, 60% of them in 37 countries and jurisdictions globally as of April 22, according to the data posted on the WHO website. The vaccines have an efficacy rate of between 50.65% and 83.5% based on phase-three clinical trials in Brazil, Turkey and Indonesia. Like Sinopharm's SARS-CoV-2 vaccine, CoronaVac uses inactivated virus to create immunity, a proven technology to fight flu and polio. These vaccines can be manufactured on a reasonable scale and they require two doses to build adequate protection.

 

Indonesia, one of the earliest to order CoronaVac and which has commenced local production, recently reported 94% efficacy in a study involving nearly 130,000 medics. In Serrana, a Brazilian city of about 45,000 people, COVID-19 casualties plunged by 70% after nearly 98% of its adult residents were vaccinated with CoronaVac, Nikkei Asia reported on May 12. Tuesday's approval comes after the WHO expressed earlier the "low level of confidence" in the quality of data submitted by Sinovac Biotech regarding the risk of serious adverse events in individuals above 60 years old. But the doubt appeared to ease with the recognition, which would also pave the way for the vaccine to qualify for the WHO-led COVID-19 Vaccines Global Access, or COVAX, initiative. "Although the Chinese vaccines have not gone through what many countries would consider a traditional clinical development pathway, the real-world evidence so far is strong," Gustav Ando, a vice president at financial data provider IHS Markit, told Nikkei Asia.

 

China has pledged to contribute 10 million doses to the COVAX initiative, which is facing a shortfall as India, the initiative's largest supplier, limits the scope of vaccine exports to tame its severe domestic outbreak. "Covishield export will be limited until June 2021," Prashant Khadayate, a pharma analyst at U.K.-based GlobalData, told Nikkei Asia, alluding to the COVID-19 vaccine produced by the Serum Institute of India. Khadayate estimates that COVAX is now projected to only deliver 145 million doses instead of 240 million by end of May, part of a broader plan to provide 2 billion doses to 190 economies in 2021. However, analysts including Khadayate do not expect a surge in demand for Chinese vaccines among developed countries even with the WHO's endorsement.

 

"Chinese vaccines lack specific trial data within the developed nations, which will impact their uptake," Khadayate said.

https://asia.nikkei.com/Spotlight/Coronavirus/COVID-vaccines/WHO-approves-second-Chinese-COVID-19-vaccine-for-emergency-use

Anonymous ID: 1fefca June 1, 2021, 12:34 p.m. No.58858   🗄️.is đź”—kun   >>8891 >>8918

>>58781pb Biden is Black today in Tulsa

 

Oklahoma names highway after Trump

 

Governor Kevin Stitt signed a proclamation Tuesday to rename US 287 roadway in Oklahoma the “Donald J. Trump Highway.” The road is 20 miles along the Texas Oklahoma border. Oklahoma has a law that a person must be dead for 3 years before naming a landmark after them. However, GOP lawmakers in the state gave this proclamation an exemption. The new name will go into effect on November 1 of this year.

https://saraacarter.com/oklahoma-names-highway-after-trump/

Anonymous ID: 1fefca June 1, 2021, 2:08 p.m. No.58882   🗄️.is đź”—kun   >>8891 >>8918

R1 RCM Inc. sold by TowerBrook Capital Partners/Ascension Health Alliance: $375.66m-May 27, June 1

 

Towerbrook founder is ex-Soros Financial Goon-see below

 

R1 RCM Announces Pricing of Secondary Offering of 15,000,000 Shares by Selling Stockholders

R1 RCM Inc. (“R1 RCM” or the “Company”) (NASDAQ: RCM) announced that it has priced the underwritten offering of 15,000,000 shares of its common stock by selling stockholders at a price to the public of $22.50 per share. The selling stockholders are TCP-ASC ACHI Series LLLP (“TCP-ASC”), a Delaware series limited liability limited partnership jointly owned by Ascension Health Alliance and investment funds affiliated with TowerBrook Capital Partners L.P., and Joseph Flanagan, the President and Chief Executive Officer of the Company.

https://www.marketscreener.com/quote/stock/R1-RCM-INC-34325398/news/R1-RCM-Announces-Pricing-of-Secondary-Offering-of-15-000-000-Shares-by-Selling-Stockholders-33361554/

 

They agreed in 2016 to buy warrants at Tree- Fiddy ($3.50/sh) and executed that on May 27 then cashed outta that with the above.

 

see this

On May 27, 2021, the Partnership exercised a warrant to purchase 16,912,646 shares of the Common Stock for $3.50 per share, pursuant to that certain Warrant No. 1 dated February 16, 2016 (the "Warrant").

https://www.sec.gov/Archives/edgar/data/1041197/000110465921075053/xslF345X03/tm2118065-1_4seq1.xml

scroll down to Response #6

 

R1 RCM Inc. is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers-AKA Debt Colelction Services. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship. The Company's PAS offering assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes. The Company also provides customers with retrospective appeal management service support for both governmental and commercial payers. Its physicians conduct detailed retrospective reviews of medical records to identify medical necessity for hospital services and the required documentation to support an appeal. Number of employees : 20 200 people.

https://www.marketscreener.com/quote/stock/R1-RCM-INC-34325398/company/

 

Ramez Sousou Founder

Mr. Sousou is founder, Co-Chair and Co-CEO of TowerBrook, Co-Chair of the Management Committee and Co-Chair of the Investment Committee. Mr. Sousou was previously Co-Head of Soros Private Equity and was a member of the Management Committee of Soros Fund Management LLC. Prior to that, Mr. Sousou was a senior member of the Principal Investment Area of Goldman Sachs in London and New York.

https://www.towerbrook.com/our-team/ramez-sousou/

 

Ascension is a faith-based healthcare organization dedicated to transformation through innovation across the continuum of care. As one of the leading non-profit and Catholic health systems in the U.S., Ascension is committed to delivering compassionate, personalized care to all, with special attention to persons living in poverty and those most vulnerable. In FY2020, Ascension provided $2.4 billion in care of persons living in poverty and other community benefit programs. Ascension includes more than 160,000 associates and 40,000 aligned providers. The national health system operates more than 2,600 sites of care – including 146 hospitals and more than 40 senior living facilities – in 19 states and the District of Columbia, while providing a variety of services including clinical and network services, venture capital investing, investment management, biomedical engineering, facilities management, risk management, and contracting through Ascension’s own group purchasing organization.

https://ascension.org/about

https://finviz.com/insidertrading.ashx?oc=1663108&tc=7&b=2

Anonymous ID: 1fefca June 1, 2021, 3:16 p.m. No.58891   🗄️.is đź”—kun   >>8904

#238

notablezzzz, not endorsements

>>58853 US Supreme Court rejects J&J talc cancer case appeal-bbc

>>58854 muh russia news JBS cyberattack hits cattle futures, sparks food fears-foxbiz

>>58857 WHO approves second Chinese COVID-19 vaccine for emergency use-nikkei

>>58858 Oklahoma names highway after Trump-saracarter.com

>>58864, >>58887, >>58888 (chek't) pf report(s)

>>58868, >>58872 Known Q Boards/Sites- as of 6-1-21-alpha order

>>58882 R1 RCM Inc. sold by TowerBrook Capital Partners/Ascension Health Alliance: $375.66m-May 27, June 1- Towerbrook founder ex co-head of Soros Private Equity

>>58883 An important message from Arizona State Senator Wendy Rogers: "they never thought we would audit everything...."-soc. media

Anonymous ID: 1fefca June 1, 2021, 3:37 p.m. No.58894   🗄️.is đź”—kun   >>8918

>>58781 pb

82-8000 USAF 747 departed Tulsa Int'l and Not AF1 Joe is no longer black

09-0015 USAF C-32A departed McConnell AFB, Wichita and on a slight hold for Not AF1 Joe

DRAMA22 USAF E-4B Nightwatch heading south from Lincoln Muni, Omaha to Dyess AFB

Interdasting timing for it's run down there considering the call sign....

SNTRY07 USAF E-3B AWACS over Tinker-AWACS are based at Tinker so not unusual

Anonymous ID: 1fefca June 1, 2021, 4:13 p.m. No.58895   🗄️.is đź”—kun   >>8896 >>8910 >>8918

>>58731 pb

Wanted confirm when it left that they had two C-32A support AC's today

Not a usual habbening.

09-0016 and 09-0017

09-0016 USAF C-32A that wuz at Tinker AFB has also departed and trailing 82-8000 back to JBA

It was first to arrive in support and last to leave

 

09-0017 USAF C-32A continues it's point position

 

SAM421 USAF G5 departed JBA west earlier-to Peterson most likely

>>58864

SAM533 G5 landed at Peterson after it's departure earlier today-sorry no cap

Anonymous ID: 1fefca June 1, 2021, 5:24 p.m. No.58900   🗄️.is đź”—kun   >>8901 >>8918

Petco Health & Wellness Co., Inc solf by CVC Capital Partners: $509.52m-June 1

 

from May 25th

Petco Health Announces Secondary Offering of 22M Shares

Petco Health and Wellness Company, Inc. (WOOF) announced that its principal stockholder, Scooby Aggregator, LP plans to sell 22 million shares of its common stock via an underwritten secondary offering. Shares of the pet health and wellness company have declined 16.4% since its IPO in January this year. In addition, the underwriters will be granted a 30-day option to purchase up to an additional 3.3 million shares. All the proceeds will go to the seller, Scooby Aggregator.

https://www.nasdaq.com/articles/petco-health-announces-secondary-offering-of-22m-shares-2021-05-25

 

They have 149,224,140 shares registered for sale after this transaction.

 

Petco Health and Wellness Company, Inc., formerly Pet Acquisition LLC, is a pet health and wellness company. The Company, through its multi-channel platform, provides products and services for pets. It offers various services, including grooming, insurance, pet adoption as well as in-store and online training. The Company also offers veterinary service platform, which includes full-service veterinary hospitals, Vetco clinics, and tele-veterinarian services. The Company operates approximately 1,500 pet care centers across the United States (U.S), Mexico and Puerto Rico, which also includes a network of more than 100 in-store veterinary hospitals, and offers a complete resource for pet health and wellness through Petco.com Website and the Petco app. The Company also operates an independent nonprofit organization, Petco Foundation.

https://www.marketscreener.com/quote/stock/PETCO-HEALTH-AND-WELLNESS-117641536/company/

 

CVC Capital Partners (Citigroup Venture Capital)

Spun out from Shitibank (dopey second largest shareholder after Qatar Sov. Fund) in 2006 (just in front of the mkt event in 2008)

they owned Formula One Group for about 10 years-made a killing and then sold controlling stake to Liberty Media-John Malone in 2016 for $4.4B

 

Established in 1981, CVC is a world leader in private equity and credit with $117.8 billion of assets under management, $161.9 billion of funds committed and a global network of 24 local offices: 16 across Europe and the Americas and eight in the Asia Pacific region. CVC is majority owned by its employees and led by its Managing Partners. CVC's private equity platform manages $89.4 billion of assets and comprises four strategies: Europe/Americas; Asia; Strategic Opportunities; and Growth Partners, each of which benefits from CVC's global platform. CVC's ability to bring to bear the full extent of its global resources on any situation gives it a competitive advantage when sourcing new investment opportunities and when creating value during CVC's ownership period.

https://www.cvc.com/about/our-firm

https://finviz.com/insidertrading.ashx?oc=1838892&tc=7&b=2